Bath & Body Works (NYSE:BBWI) Issues FY26 Earnings Guidance

Bath & Body Works (NYSE:BBWI) issued an update on its FY26 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $3.25-360 for the period, compared to the consensus earnings per share estimate of $3.61. Bath & Body Works also updated its Q1 guidance to $0.36-0.43 EPS.

Analysts Set New Price Targets

Several analysts have issued reports on BBWI shares. Argus reaffirmed a “hold” rating on shares of Bath & Body Works in a research report on Friday, January 10th. Morgan Stanley cut their target price on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research note on Thursday, November 21st. Raymond James restated an “outperform” rating and issued a $46.00 price objective (up previously from $42.00) on shares of Bath & Body Works in a research note on Tuesday, February 25th. Citigroup upgraded Bath & Body Works from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $40.00 to $48.00 in a research note on Friday, February 28th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Five analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $45.06.

Bath & Body Works Stock Down 6.6 %

NYSE BBWI opened at $30.45 on Tuesday. The firm has a 50-day moving average price of $37.09 and a two-hundred day moving average price of $34.14. Bath & Body Works has a 12-month low of $26.20 and a 12-month high of $52.99. The company has a market capitalization of $6.60 billion, a P/E ratio of 7.43, a P/E/G ratio of 0.92 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $2.04 by $0.05. The company had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. Equities analysts expect that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 2.63%. The ex-dividend date of this dividend was Friday, February 21st. Bath & Body Works’s dividend payout ratio (DPR) is currently 21.98%.

Bath & Body Works declared that its board has approved a share buyback plan on Thursday, February 27th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to buy up to 6.4% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.